What does it mean if my report also mentions “atypical ductal hyperplasia (ADH)” or “atypical lobular hyperplasia (ALH)”?
These are precursors to ductal carcinoma in-situ and lobular carcinoma in-situ, respectively. The significance of these changes often depends on the associated lesions and is best discussed with your treating physician.16. What does it mean if my report also says any of the following terms: “usual duct hyperplasia”, “adenosis”, “sclerosing adenosis”, “radial scar”, “complex sclerosing lesion”, “papillomatosis”, “papilloma”, “apocrine metaplasia”, “cysts”, “columnar cell change”, “collagenous spherulosis”, “duct ectasia”, “fibrocystic changes”, “flat epithelial atypia”, or “columnar cell change with prominent apical snouts and secretions (CAPSS)”?All of these terms are non-cancerous changes that the pathologist sees under the microscope and are of no importance when seen on a biopsy where there is in-situ cancer.
Related Questions
- What does it mean if my report on ductal carcinoma in-situ (DCIS) mentions "estrogen receptor (ER)" or "progesterone receptor (PR)"?
- What does it mean if my report also mentions "atypical ductal hyperplasia (ADH)" or "atypical lobular hyperplasia (ALH)"?
- What is atypical ductal hyperplasia (ADH) of the breast?
